Nutraceutical with Anti-Inflammatory Activity for the Management of Airway Remodeling in Bronchial Asthma: Kalanchoe integra Var. Crenata (Andr.) Cuf Leaf Extract ()
Keywords:Kalanchoe Integra; Asthma; Bronchoconstriction; Goblet Cells; Perivascular Oedema
1. Introduction
Plant-derived medicines in recent time have immensely contributed to the management of disease conditions in humans [1] . Kalanchoe integra (syn. Kalanchoe spanthulata, Bryophyllum pinnata) [2] [3] is emerging plant of interest of multipurpose use. Boiled leaf extracts are useful in the management of acute and chronic bronchitis, pneumonia, bronchial asthma and palpitation [4] -[6] . This plant has also shown various pharmacological activities such as anthelmentic, immunosuppressive, wound healing, hepatoprotective, antinociceptive, anti-inflammatory, antidiabetic, nephroprotective, antioxidant, antimicrobial, analgesic, anticonvulsant, and antipyretic activity. In South-Eastern Nigeria, this herb is used to facilitate the dropping of the placenta of new-born babies [7] -[11] .
Bronchial asthma is a multi-factorial disease process with both genetic and allergic origin characterized by bronchial airway inflammation, increased mucous production and airway hyperresponsiveness [12] -[14] . The prevalence of asthma, along with asthma-associated morbidity and mortality, continues to increase worldwide, making the disease an important target for the biopharmaceutical industry. The development of new therapeutics therefore depends on suitable pre-clinical models; the goal of which is to reproduce airway inflammation, mucus hypersecretion or airway hyper-responsiveness as occurs in humans [15] -[17] . Agents targeting the mechanisms involved in eosinophil and neutrophil activation and accumulation also serve as important therapeutic strategies [15] -[20] .
Leaf of Kalanchoe integra contains flavonoids (quercetin) and tannins which have been found to have beneficial effects in the management of bronchial asthma [21] -[24] while the anti-histaminic and anti-anaphylactic effects of Kalanchoe sp have also been demonstrated by researchers [9] [25] . Previous studies have shown the ameliorating effect of Kalanchoe integra leaf extract on bronchial hyperesponsiveness and inflammation [26] . Further, the stabilizing effect of Kalanchoe sp on mast cell degranulation, suggests that Kalanchoe sp could be potential candidates for allergic asthma therapy. It is against this background that this study is being conducted in an attempt to demonstrate the anti-asthmatic potential of Kalanchoe integra leaf extract [KILE].
2. Materials and Methods
2.1. Collection and Identification of Plant Material
Fresh leaves of Kalanchoe integra were obtained from the Botanical Gardens of the University of Ghana. The collection was done mid-July because the leaves are known to possess high concentrations of its medicinal actives during this season. The leaves were sent to the Botany Department of the University of Ghana for identification, authentication and storage at the herbarium, botany department, University of Ghana Legon for reference purposes. A sample was deposited with identification number IAGSP-001. The fresh leaves were washed thoroughly under running tap water and air dried under the shade for three weeks and pulverized into coarse powder.
2.2. Preparation of Plant Extract
3 kg of dried Kalanchoe integra leaves were washed and blended, macerated using 12 litres of hot distilled water, decanted and sieved. The concentrated extract was freeze dried. Powdered sample of the plant extract was weighed, labeled and stored in sterile bottles. Two hundred grams (200 g) of the coarse powder was put into a beaker and macerated with four litres of distilled water for 48 hours. The supernatant was filtered using a funnel plugged with cotton wool. The filtrate was concentrated under vacuum in a rotary evaporator at 50˚C - 60˚C. The concentrate was stored in an airtight container at 6˚C ± 2˚C. This concentrate was then freeze dried. The freeze dried extract was 426 g with a percentage yield of 14.2%.
2.3. Animal Husbandry
Thirty (30) guinea pigs of both sexes weighing between 400 and 600 g were purchased from the Noguchi Memorial Institute for Medical Research, University of Ghana. The animals were quarantined in an air-conditioned room for 7 days at a temperature of 22˚C ± 1˚C with relative humidity of 60% ± 1% and 12 h light/dark cycle at animal experimentation department of NMIMR. They were fed with autoclaved Sankofa goat and sheep pellet diet from Ghana Agro Food Company (GAFCO) and water ad libitum every morning throughout the study.
Spontaneous behaviors of all guinea pigs were observed in cages before experimental procedures were carried out.
2.4. Animal Groupings
The guinea pigs were put into five groups of 6 animals each. Two ovalbumin-sensitized groups receiving the Kalanchoe integra in high (HDK = 900 mg/kg) and low (LDK = 300 mg/kg) doses respectively, ovalbumin-sensitized control group received prednisolone (PRED = 2.5 mg/kg), OA-sensitized control group (SC), Non-sensitized control (NORM or intact animals). All experimental procedures conformed to the OECD guidelines [27] [28] and the study protocol approved by the Scientific and Technical Committee (STC) and the Noguchi Memorial Institute for Medical Research Institutional Animal Care and Use Committee (NIACUC), College of Health Sciences, University of Ghana.
2.5. Sensitization of Experimental Animals
Ovalbumin and Aluminum hydroxide were obtained from the Biochemistry department, University of Ghana and used to induce the allergic asthma and boost the allergy respectively according to Awortwe et al. (2011) [29] with slight modifications.
All animal groups (except the non-sensitized negative controls) were sensitized with 10 mg of ovalbumin and 30 mg aluminum hydroxide intraperitoneally and subcutaneously at day zero.
2.6. Immune Boosting Procedure
0.1 ml of 0.9% saline containing only 15 mg ovalbumin without adjuvant was administered to the sensitized guinea pigs by intraperitoneal route on day 14. The guinea pigs were observed for a period of one week after immune boosting. The diameter of the wheal for each guinea pig was monitored, as well as breathing patterns, eyes, motor activity and sensitivity to touch, for a period of one week till day 21.
2.7. Ovalbumin Challenge, Drug Treatment and Skin Prick Test
On the 25th day through to 56th day, sensitized guinea pigs were challenged with 2% aerosolized OA (0.2 g OA dissolved in 10 ml saline) for 10 min after 1 hour treatment with High dose Kalanchoe (HDK), Low dose Kalanchoe (LDK) and Prednisolone, PRED (2.5 mg/kg) respectively. OA-sensitized controls were challenged with 0.1 ml of 0.9% saline for the same duration. The challenge was conducted in Perspex chamber (dimensions = 20 × 30 cm) connected to jet nebulizer.
Skin prick test was used as an indirect measurement of IgE levels in the sensitized guinea pigs [29] [30] . The skin prick test was performed on day 56 by injecting 1% ovalbumin intradermally on the back of each guinea pig after the fur was shaken (Figure 1).
2.8. Haematological Studies
Guinea pigs were anesthetized with 50 mg/kg sodium phenobarbitone. Two millilitres (2 ml) of blood was drawn by cardiac puncture and transferred into EDTA test tube. An automated haematology analyzer (KX-2IN, Sysmex Corporation, Japan) was used to estimate the counts of neutrophils, lymphocytes, eosinophils and total leukocytes in each blood sample.
Figure 1. Schematic diagram of the experimental protocol indicating the events and durations.
2.9. Histological Studies
On the 56th day, the guinea pigs were euthanized and blood taken by cardiac puncture. The lungs were swiftly excised from the thoracic cavity and washed immediately with 0.9% saline (four times). The tissues were fixed with 10% neutral buffered formaldehyde (pH = 7.4), embedded in paraffin wax (56˚C to 60˚C) and sectioned at 4 μm for histopathological examination. The sectioned tissues were stained with hematoxylin and eosin (H&E). Lung sections were evaluated microscopically using Olympus BX 51TF (Olympus Corporation, Tokyo, Japan) light microscope connected to a digital camera for morphology in the bronchioles. Images of selected sections were captured at 20× magnification.
For goblet cell identification, the periodic acid stain (PAS) stain was used while the PAS + AB (periodic acid Schiff + alcian blue) were used to differentiate between acid mucins and neutral mucins.
2.10. Statistical Analysis
Statistical analysis was done using Graphpad Prism 5. Means ± SEM were determined for quantitative variables. In all cases values are expressed as mean ± SEM. Statistics were performed using analysis of variance (ANOVA) was used to determine statistical significance invariables among the groups at p-values ≤ 0.05 with subsequent Bonferroni post hoc test. p-values of less than 0.05 were considered significant.
3. Results
3.1. Haematological Studies
The counts of lymphocytes in the groups PRED, HDK, LDK, were 1300 ± 30 µL, 5100 ± 24 µL, 6000 ± 45 µL. One way ANOVA showed a significant difference (p < 0.001) in the lymphocyte counts of the five groups of animals. The counts of neutrophils in the groups PRED, HDK, LDK, were 2700 ± 63 µL, 2700 ± 67 µL, 2900 ± 33 µL. One-way ANOVA show significant differences in the neutrophil count for the five groups (p = 0.0060). Benferroni’s multiple comparison showed no significant difference between comparison between PRED and other groups (p > 0.05). The counts of eosinophils in the groups PRED, HDK, LDK were 248 ± 22.7 µL, 325 ± 17 µL, 400 ± 25 µL. One-way ANOVA showed no significant differences between the groups (p = 0.0149) as shown in Figure 2.
3.2. Histological Studies
The figures below show the lung tissues from the groups ovalbumin sensitized controls (SC) (Figure 3), 900 mg/kg HDK (Figure 4), 2.5 mg/kg PRED (Figure 5) and normal (non-sensitized) guinea pigs (Figure 6) showing a description of the salient pathological features relevant to this study.
3.3. Key
Alveolus (a), Bronchiole (b), Blood Vessel (v), Peribronchial edema (e), Leukocystis Alveolitis (la), Pneumocystis (p), Perivascular edema (pe), Goblet cells (g), Smooth muscle (s), Emphysema (em), Bronchial Lumen (lu).
3.3.1. Bronchial Smooth Muscle
Guinea pigs administered with prednisolone exhibited bronchial smooth muscle thickness with an average of 1.9 ± 0.994429. Similar observations were found in High Dose Kalanchoe with an average of 1.7 ± 0.875595. The
Figure 2. Changes in immune parameters during high dose (900 mg/kg) and low dose (300 mg/kg) Kalanchoe integra administration. Values are expressed as mean ± SEM, n = 6. The difference among means has been analyzed by ANOVA followed by bonferroni’s multiple comparison. Values of p < 0.05 were considered as statistically significant. *p < 0.05, **p < 0.01 and ***p < 0.001 when compared with k. integra.
rest in the respective groups exhibited slightly reduced bronchial smooth muscle with an average of 2.2 ± 0.632456 and 2.4 ± 0.516398.
3.3.2. Goblet Cell Accumulation Evaluation
Guinea pigs in the Kalanchoe treated group exhibited reduced goblet cell accumulation in the bronchioles com-
pared to the controls.
3.3.3. Co-Morbidities
Hypersensitivity Pneumocystis was exhibited by all animals in all the groups with the exception of those administered with prednisolone. Three out of the six animals in the prednisolone group exhibited or maintained an appreciable normality in their alveoli architecture.
Emphysema was exhibited by all animals in all the groups with the exception of those administered with prednisolone.
3.3.4. Bronchoconstriction
Increased bronchial smooth muscle thickness and goblet cell accumulation usually indicates bronchoconstriction.
4. Discussion
In this study, the antiasthmatic potential of the nutraceutical KILE has been investigated. Pathophysiological parameters of bronchial asthma investigated include bronchial folds, bronchial wall thickness, alveoli, alveolar sacs, alveolar ducts and blood vessel walls. The immune parameters were also investigated.
Ovalbumin sensitized guinea pigs were preferred as experimental models for this study because they readily show airway hyper-reactivity and eosinophilia [29] [31] [32] . Ovalbumin-sensitized guinea pigs were challenged by inhalation of aerosolized ovalbumin antigen since asthmatic human subjects also experience airway hyperreactivity through similar route of antigen challenge [33] [34] . The inhalation of ovalbumin aerosols increased bronchial responsiveness: bronchoconstriction, hypertrophy of airway smooth muscle, infiltration of eosinophils and basophils, emphysema, peribronchial and perivascular oedema in the lungs of ovalbumin sensitized control guinea pigs compared to non-sensitized controls (Figure 3, Figure 6). These histological lesions observed in the lungs of ovalbumin sensitized guinea pigs are consistent with other findings [29] when a similar protocol was used to assess the anti-asthmatic actions of Taraxacum officinalis. It has been recognised for many years that patients who die from acute asthma attacks have grossly inflamed airways [35] [36] . Lymphocytes count during the experiment showed a significant difference (p < 0.0001) between lymphocytes counts of KILE administered guinea pigs as compared to the negative controls (Figure 2). Also, the lymphocyte count for prednisolone treated group of guinea pigs was averagely 1300 counts/µL (Figure 2) demonstrating the immunosuppressive effects of prednisolone as a corticosteroid. Other studies conducted [37] [38] portrayed a similar pattern.
Apart from the fact that phagocytes are among the many inflammatory cells and mediators released during severe infections or antigenic exposure in the lungs, neutrophils are also implicated in exacerbations of acute bronchial asthma [38] -[40] . Neutrophils count during the experiment indicated only a significant difference between High dose KILE group 2500 counts/µL (Figure 2) and the prednisolone treated groups (p < 0.0001). The ability of KILE to reduce both neutrophils and lymphocyte counts indicates its possible immunosuppressive effects and anti-asthmatic properties. Similar effects have been observed using extracts of Taraxacum officinalis [29] . However, recent observation that neutrophils undergo apoptosis rather than necrosis in the airways and alveoli is essential to defining pulmonary inflammation and repair [41] -[43] .
KILE’s significant reduction in the eosinophil and lymphocytes counts might have contributed to maintaining alveoli architecture compared to the sensitized negative control. A similar observation was made in the prednisolone treated animal groups and these are confirmed by other studies involving antiasthmatic agents [44] -[46] .
Degranulation of eosinophils after infiltration into the lungs is a key player in the pathogenesis of asthma [47] [48] . Eosinophil activation produces a host of cationic proteins such as Major Basic Protein (MBP), Eosinophil Peroxidase (EPO) and eosinophil derived neurotoxin (EDN). Evidence from several studies has shown that these proteins are capable of damaging structures in the lung tissue while infiltrations of neutrophils in the lungs are increasingly being associated with exacerbations of acute asthma [47] [48] . KILE administration reduced these parameters as compared to the controls Evaluating the ability of KILE to restore the already compromised bronchial airway patency as observed in the sensitized guinea pigs [negative control], the extent of bronchial smooth muscle hypertrophy or hyperplasia and goblet cell accumulation were monitored. Goblet cells are responsible for the production of mucin which later forms mucus in water. The higher the number of cells the more resulting mucus will be reduced which reduces the lumen of the bronchiole [51] -[53] . Goblet cells producing mucus on the other hand will stop the production of excess mucus once the exposure to the allergen is stopped much less when the cells die and the production of the mucus is reduced [52] [54] . Both smooth muscle thickness and number of goblet cells correlate with the degree of airway obstruction in this disease, supporting a role for airway remodelling and mucus hypersecretion in the development of airflow limitation in asthmatics [17] [19] [20] . Besides, thickening of the airway wall, hypertrophy of mucous glands, increased smooth muscle mass and hyperplasia of goblet cells have been reported in patients with COPD [55] -[57] .
KILE exhibited reasonable reduction in goblet cell accumulation (Figure 4), a situation considered non-critical especially when other pathological parameters remain normal or reduced. Prednisolone on the other hand shows slight effect against HP since it was able to maintain normality to aspects of the guinea pig alveoli architecture (Figure 5). Emphysema, which has also been found in ovalbumin sensitized guinea pigs (Figure 3) was also reduced by KILE (Figure 4).
Bronchial smooth muscle thickness is a parameter of primary importance due to its irreversible nature [12] . Both LD and HD KILE appreciably reduced bronchial smooth muscle hypertrophy, hyperplasia and subepithelial fibrosis which are very characteristic of bronchial asthma [12] [18] [35] . This corresponded to a reduced bronchial smooth muscle thickness (Figure 4) which in this case could be considered non critical because other parameters leading to bronchoconstriction remain reduced or normal. Prednisolone however had a more pronounced effect in reducing smooth muscle hypertrophy or hyperplasia and subepithelial fibrosis (Figure 5).
One peculiar observation in this study is the presence of both immediate-phase and late-phase asthmatic responses in the photomicrographs of the ovalbumin sensitized guinea pigs. Immediate-phase asthmatic response was evidenced by the presence of bronchoconstriction (Figure 3) whilst recruitment of eosinophils and basophils, hypertrophy of the trachealis muscle, emphysema, peribronchial oedema and perivascular oedema (Figure 3) were signs for late-phase asthmatic response [16] [58] -[60] . KILE reduced these parameters as compared to the negative controls. It would be desirable to elucidate the mechanism by which KILE exhibits this effect and to isolate and characterize the compounds responsible.
The above observations contribute to the pharmacological validation that KILE when taken orally for long periods could be beneficial in the management of bronchial asthma. This could partly be explained by kalanchoe’s antioxidant properties as well as the presence of quercetin in KILE because previous studies have implicated quercitrin as having an anti-inflammatory and bronchodilatatory effect therefore it is possible that this same flavonoid in K. integra together with phenolic and tannin compounds may also be responsible its antiasthmatic activity [24] [49] [50] . The active components of KILE are recommended to be further investigated.
5. Conclusion
Kalanchoe integra leaf extract reduces bronchoconstriction, immune responses, goblet cell accumulation and smooth muscle thickness comparable to prednisolone. The above effects prove that KILE is a promising nutraceutical having anti-asthmatic potential.
Acknowledgements
The authors acknowledge the “manuscript writing” financial support of “Building Stronger Universities Initiative Platform on Human Health” (BSU-PHH)-Department of Pharmacology and Toxicology, University of Ghana School of Pharmacy, College of Health Sciences.
Abbreviations
KILE: Kalanchoe integra leaf extract;
SC: sensitized control;
LD: low dose;
HD: high dose;
LDK: low dose kalanchoe;
HDK: high dose kalanchoe;
PRED: prednisolone;
Alveolus (a);
Bronchiole (b);
Blood Vessel (v);
Peribronchial edema (e);
Leukocystis Alveolitis (la);
Pneumocystis (p);
Perivascular edema (pe);
Goblet cells (g),;
Smooth muscle (s);
Emphysema (em);
Bronchial Lumen (lu).
NOTES
*Corresponding author.